ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc (VNDA)

4.58
-0.04
( -0.87% )
Updated: 10:32:31

Empower your portfolio: Real-time discussions and actionable trading ideas.

VNDA News

Official News Only

VNDA Discussion

View Posts
eyeownu eyeownu 3 weeks ago
im a buyer at 5.07.nice triangle has formed. low float. plenty of cash on balance sheet. book value 9.20/sh
πŸ‘οΈ0
Zilla Zilla 2 months ago
WOW talk about being lucky. Bought calls Friday for 2025 just in case something happens in 2024. Up 20% pre-market with an 8 all cash offer on the table.
πŸ‘οΈ0
Monksdream Monksdream 3 months ago
VNDA under $7
πŸ‘οΈ0
harry crumb harry crumb 5 months ago
Watching this closely
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
VNDA under $10
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
Over $6
πŸ‘οΈ0
tw0122 tw0122 6 months ago
Vanda acquired U.S. and Canadian rights to PONVORY® from a Johnson & Johnson Company on December 7, 2023. PONVORY® is approved by the U.S. Food and Drug Administration (FDA) and Health Canada to treat adults with relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease (RMS).

In anticipation of the commercial launch of PONVORY® for RMS in the third quarter of 2024, Vanda is initiating a host of commercial activities including the creation of a specialty sales force, a prescriber awareness program and a comprehensive marketing program.
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Gonna be a winner. Patience
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Over 5$!
πŸ‘οΈ0
Monksdream Monksdream 7 months ago
VNDA under $5
πŸ‘οΈ0
harry crumb harry crumb 7 months ago
Let er rip $$$$$$$$
πŸ‘οΈ0
Tiger Money Tiger Money 8 months ago
Agreed. This could double quickly
πŸ‘οΈ0
philaya philaya 8 months ago
got this today...
very good trades.
πŸ‘οΈ0
harry crumb harry crumb 8 months ago
This little gem could run up fast, they obviously have their science going in the right direction as the offers are there just not the price, could be a 10.00 offer in the works
πŸ‘οΈ0
morokoy morokoy 8 months ago
Shares Outstanding 57,537,499 shares
Insider Shares 7,908,897 shares
Insider Ownership 13.75 %
Total Insiders 34
πŸ‘οΈ0
morokoy morokoy 8 months ago
"The dividend distribution of rights will be payable to stockholders of record as of the close of business on April 29, 2024."

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends.

A shareholder may also receive distributions such as additional stock or stock rights in the distributing corporation; such distributions may or may not qualify as dividends. You should receive a Form 1099-DIV, Dividends and Distributions from each payer for distributions of at least $10.

Guess we'll have to wait on the promised 8K.

Additional details of the Rights Plan will be contained in a Form 8-K to be filed by the Company with the U.S. Securities and Exchange Commission (the "SEC"). The filing will be available on the SEC's website at www.sec.gov.
πŸ‘οΈ0
harry crumb harry crumb 8 months ago
Minimum 8$ imo
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
Vanda Pharmaceuticals rejects takeover proposal from Future Pak
REUTERS
1 mins ago
April 17 (Reuters) - Vanda Pharmaceuticals Inc (VNDA.NaE) on Wednesday said it is rejecting a takeover proposal from Future Pak, a privately-held contract manufacturer and packager of pharmaceuticals, as it significantly undervalues the company.

(Reporting by Sriparna Roy in Bengaluru; Editing by Tasim Zahid)
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️ 1
MiamiGent MiamiGent 8 months ago
Probably...but I took it at 5.49
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Will it grow legs after 9:30
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA Vol picking up..

$5.49 +$1.44 (+35.56%)

Volume 3,354,569

90 DAV... 2M
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA Here we go
$5.3781 +$1.3281 (32.79%)

Bid ARCX
5.36 x 10
Ask XNMS
5.38 x 11
Volume
2,971,106
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA Vol is good. Already @ 90 DAV
Volume 2,056,421
10/90-day avg. volume
7M / 2M
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA Good post, Laster.
https://www.futurepak.com/
πŸ‘οΈ0
Laster Laster 8 months ago
The major question is who is Future Pak really?
Is this a legit offer?
Either way, company is extremely undervalued with no debt (I believe) and lots of cash.
Large short position. Lots of selling PM at $5.
Market does not seem to believe this offer. Sorry.
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA Float 52.05M

Shares Short (3/28/2024) 2.49M
Short Ratio (3/28/2024) 2.78
Short % of Float (3/28/2024) 5.45%
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA
Bid EDGX
4.85 x 3
Ask EDGX
4.88 x 3

Volume
1,790,654
Avg Vol (10 day) 6.63M
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
Vanda Pharmaceuticals
Closed .01 (-0.25%)

Pre-market
$5.15 +1.10 (+27.16%)
As of Apr-17-2024 7:23:52 AM ET
Bid x size $5.14 x 1
Ask x size $5.16 x 3
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
VNDA In 5.12. Let's see, said the blind man.
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
Vanda Pharmaceuticals jumps 38% on Future Pak's latest buy offer
Apr. 17, 2024 6:41 AM ETVanda Pharmaceuticals Inc. (VNDA) Stock
πŸ‘οΈ0
MiamiGent MiamiGent 8 months ago
What's the news?
πŸ‘οΈ0
Awl416 Awl416 8 months ago
Damn
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Will it grow legs after 9:30
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
Will it grow legs after 9:30
πŸ‘οΈ0
tknuncle tknuncle 10 months ago
I have been acquiring since $3.90. I wish that I would have waited longer lol but, like what I see with VNDA. Was going to grab the last of my starter position soon. GLTA
πŸ‘οΈ0
weedtrader420 weedtrader420 10 months ago
FDA Approve
πŸ‘οΈ0
Triple nickle Triple nickle 1 year ago
Fda accepts new drug application for tradipitant in the after hours today
👍️ 1
jgrabar jgrabar 3 years ago
$VNDA -On May 19, 2022, Vanda Pharmaceuticals agreed to settle a securities fraud class action complaint (the β€œComplaint”) for $11.5 Million. https://grabarlaw.com/the-latest/vanda-pharmaceuticals-investigation/
πŸ‘οΈ0
RNsidersbuying RNsidersbuying 4 years ago
VNDA 12.34 - FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome

https://ih.advfn.com/stock-market/NASDAQ/vanda-pharmaceuticals-VNDA/stock-news/83807075/fda-approves-hetlioz-tasimelteon-for-the-treatmen
πŸ‘οΈ0
XenaLives XenaLives 4 years ago
Everything would be a lot better if the govt. would just let doctors treat COVID like another flu bug. The drama is getting old.
πŸ‘οΈ0
Peepson Peepson 4 years ago
Yo, this thing is going to trade sideways for a while. They have a drug that could help with covid but so does every other pharma company. Its a safe hold imo but nothing will happen fast i don't think
πŸ‘οΈ0
XenaLives XenaLives 4 years ago
What's up? Doesn't seem to be much interest. I was looking at the chart but haven't found much on the company yet.

πŸ‘οΈ0
otcmoneydoubler otcmoneydoubler 4 years ago
LOL. VNDA GOT NEWS TODAY. SO WHAT DD HAVE YOU GOT TO SHARE?
πŸ‘οΈ0
Peepson Peepson 4 years ago
Yo, does anyone still follow this board. I might have some interesting dd to share.
πŸ‘οΈ0
bezen bezen 8 years ago
https://finance.yahoo.com/news/jefferies-5-top-biotech-stocks-133534894.html
πŸ‘οΈ0
Coz Mabluda Coz Mabluda 8 years ago
Brett Jensen. SA article re VNDA. Expects positive analyst's review.

Vanda Pharmaceuticals (NASDAQ:VNDA) posted solid third quarter results on Thursday. Instead of losing a dime a share as expected, the company posted a profit of 11 cents a share. Revenue was also up more than 35% from the same period a year ago. The company now looks like it could be profitable in FY2017. I expect some positive analyst commentary on this name by analysts over the next week. Vanda has a solid pipeline and over $140 million in cash and marketable securities on the balance sheet. One has to like the company's growth trajectory and the concern seems undervalued with just a $600 million market capitalization.



πŸ‘οΈ0
stocktrademan stocktrademan 8 years ago
fast and steady profit scan VNDA bullish 16.64



normal chart


log chart

πŸ‘οΈ0
ClearlyStocks ClearlyStocks 8 years ago
VNDA $16.74
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock